Half-year report · Q2
6323.TEDINET S100UJ0W
Period2024-03-01 → 2024-08-31
Filed2024-10-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥60.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥93.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥41.0bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Operating income | ¥17.1bn | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Operating income | ¥10.0bn | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Ordinary income | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥27.1bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.9bn | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.9bn | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥15.8bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.8bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥16.2bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Net income | ¥10.2bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Total assets | ¥184.7bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥156.1bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥150.0bn | at 2023-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.5bn | at 2024-08-31 | Cons. | Liabilities |
| Total liabilities | ¥56.6bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥124.2bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥99.5bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥90.1bn | at 2023-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥55.1bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥38.0bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash & equivalents | ¥54.9bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥38.0bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.6bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.3bn | at 2023-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20.1bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.2bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.7bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥792m | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥89.97 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥111.11 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.82 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥89.85 | 2024-03-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥110.91 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.72 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.6% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.1% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-08-31 | −¥108m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-08-31 | −¥108m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-08-31 | −¥410m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥334m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥334m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2024-03-01 → 2024-08-31 | −¥52m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥60.0bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥59.9bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥108m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2024-03-01 → 2024-08-31 | ¥17.6bn |
| —segment total | revenue | 2024-03-01 → 2024-08-31 | ¥60.3bn |
| —segment total | revenue external | 2024-03-01 → 2024-08-31 | ¥60.2bn |
| —segment total | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥108m |
| —segment total | segment profit | 2024-03-01 → 2024-08-31 | ¥17.6bn |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-08-31 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-08-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-08-31 | −¥247m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥152m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥152m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2023-03-01 → 2023-08-31 | −¥97m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥40.8bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥40.8bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥3m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥10.3bn |
| —segment total | revenue | 2023-03-01 → 2023-08-31 | ¥41.0bn |
| —segment total | revenue external | 2023-03-01 → 2023-08-31 | ¥41.0bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥3m |
| —segment total | segment profit | 2023-03-01 → 2023-08-31 | ¥10.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 528
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | Prior1YearInstant | 36430000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 40704000000 | JPY |
| Long term loans payable | Prior1YearInstant | 18167000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 17739000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 423000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 440000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 82000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 89000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 302000000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 351000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 997000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 720000000 | JPY |
| Other ncl | Prior1YearInstant | 182000000 | JPY |
| Other ncl | CurrentQuarterInstant | 466000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 20156000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 19808000000 | JPY |
| Liabilities | Prior1YearInstant | 56586000000 | JPY |
| Liabilities | CurrentQuarterInstant | 60513000000 | JPY |
| Capital stock | Prior1YearInstant | 982000000 | JPY |
| Capital stock | CurrentQuarterInstant | 982000000 | JPY |
| Capital surplus | Prior1YearInstant | 5231000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 4923000000 | JPY |
| Retained earnings | Prior1YearInstant | 78465000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 91937000000 | JPY |
| Treasury stock | Prior1YearInstant | -3000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -55000000 | JPY |
| Shareholders equity | Prior1YearInstant | 84677000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 97787000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 292000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 255000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 7243000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 13832000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 7535000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 14088000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 85000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 5000000 | JPY |
| Non controlling interests | Prior1YearInstant | 7251000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 12331000000 | JPY |
| Net assets | Prior1YearInstant | 99550000000 | JPY |
| Net assets | CurrentQuarterInstant | 124212000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 156136000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 184726000000 | JPY |
| Net sales | Prior1YTDDuration | 40992000000 | JPY |
| Net sales | CurrentYTDDuration | 60229000000 | JPY |
| Cost of sales | Prior1YTDDuration | 26123000000 | JPY |
| Cost of sales | CurrentYTDDuration | 36485000000 | JPY |
| Gross profit | Prior1YTDDuration | 14868000000 | JPY |
| Gross profit | CurrentYTDDuration | 23743000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 4916000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 6597000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |